You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 21, 2025

Drug Price Trends for SM GENTLE LAXATIVE EC


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for SM GENTLE LAXATIVE EC

Average Pharmacy Cost for SM GENTLE LAXATIVE EC

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SM GENTLE LAXATIVE EC 5 MG TAB 49348-0032-10 0.03866 EACH 2024-12-18
SM GENTLE LAXATIVE EC 5 MG TAB 49348-0032-05 0.03866 EACH 2024-12-18
SM GENTLE LAXATIVE EC 5 MG TAB 49348-0032-10 0.03714 EACH 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for SM Gentle Laxative EC

Market Overview of Laxatives

The global laxatives market is experiencing significant growth, driven by several key factors. The market was valued at USD 7,064.29 million in 2021 and is projected to reach USD 11,516.87 million by 2029, with a CAGR of 6.30% during the forecast period of 2022 to 2029[3].

Drivers of the Laxatives Market

  • Lifestyle Trends and Constipation Prevalence: Sedentary lifestyles and poor dietary habits are increasing the risk of constipation, thereby boosting the demand for laxatives. The higher prevalence of constipation in the geriatric population is another significant driver[1][4].
  • Emerging Markets: Regions such as Asia Pacific, Latin America, and the Middle East & Africa present lucrative opportunities for growth due to increasing healthcare awareness and improving economic conditions[1][4].
  • Technological Advancements: Investments in developing advanced technologies and new formulations are enhancing market growth. The rise of online retail and e-commerce platforms has also transformed the distribution of laxatives, making them more accessible to consumers[3][4].

Market Segments and Competitive Landscape

The laxatives market is segmented by drug type, including stimulant laxatives (e.g., senna, bisacodyl), osmotic laxatives (e.g., polyethylene glycol), and stool softeners (e.g., docusate, methylcellulose). Bisacodyl, the active ingredient in SM Gentle Laxative EC, falls under the stimulant laxatives category[1][4].

  • Bisacodyl Market: As a widely used stimulant laxative, bisacodyl is expected to maintain a significant market share. The demand for bisacodyl is driven by its effectiveness in treating constipation and its availability in various formulations, including oral delayed-release tablets and rectal suppositories[2][4].

Price Analysis for SM Gentle Laxative EC

The pricing of SM Gentle Laxative EC, which contains bisacodyl, can vary based on several factors including the pharmacy, location, and availability of discounts.

  • Current Pricing: The cost for Gentle Laxative (bisacodyl) 5 mg oral delayed-release tablets can range from $9.94 for 25 tablets to $11.09 for 100 tablets, depending on the pharmacy and any available discounts[2].
  • Discounts and Coupons: Consumers can use discount cards, such as the Drugs.com Discount Card, to save up to 80% on the cost of prescription and over-the-counter medications, including laxatives[2].

Regional Market Dynamics

The laxatives market is geographically diverse, with different regions exhibiting varying growth rates.

  • North America: This region dominates the market due to government measures supporting the use of single-use medical supplies and the presence of prominent market players. The US holds the largest market share in North America[4].
  • Europe: Europe accounts for the second-largest market share, driven by the growing number of individuals suffering from chronic constipation. Germany holds the largest market share in Europe[4].
  • Asia-Pacific: This region is expected to grow at the fastest CAGR due to the adoption of advanced technologies and the growing demand for minimally invasive procedures. China and India are key markets in this region[4].

Challenges and Restraints

Despite the growth, the laxatives market faces several challenges:

  • Side Effects: Potential side effects such as diarrhea, dehydration, and blood in the stool can impede market growth[3][4].
  • Regulatory Standards: Strict regulatory standards and the need for education on proper laxative use are additional challenges[3][4].
  • High Development Costs: The high cost of drug development and distribution, along with the lack of healthcare infrastructure in developing economies, can also hinder market growth[3].

Future Outlook and Price Projections

Given the current trends and drivers, here are some key projections:

  • Market Growth: The laxatives market is expected to continue growing, driven by increasing prevalence of constipation, technological advancements, and expanding distribution channels[3][4].
  • Price Stability: Prices for laxatives, including SM Gentle Laxative EC, are likely to remain relatively stable, with potential minor fluctuations based on market competition and regulatory changes. However, the availability of generic versions and discount programs can help keep prices affordable for consumers[2].

Key Takeaways

  • The global laxatives market is projected to reach USD 11,516.87 million by 2029.
  • Bisacodyl, the active ingredient in SM Gentle Laxative EC, is a significant segment within the stimulant laxatives category.
  • Prices for SM Gentle Laxative EC can range from $9.94 to $11.09 for different quantities, with discounts available through various programs.
  • Regional dynamics vary, with North America and Europe being major markets, and Asia-Pacific showing the fastest growth.
  • Challenges include potential side effects, regulatory standards, and high development costs.

Frequently Asked Questions (FAQs)

Q: What is the projected growth rate of the global laxatives market? A: The global laxatives market is expected to grow at a CAGR of 6.30% from 2022 to 2029[3].

Q: What are the main drivers of the laxatives market? A: The main drivers include lifestyle trends increasing the risk of constipation, higher prevalence of constipation in the geriatric population, and emerging markets presenting lucrative opportunities for growth[1][4].

Q: How does the pricing of SM Gentle Laxative EC vary? A: The pricing can vary based on the pharmacy, location, and availability of discounts, ranging from $9.94 for 25 tablets to $11.09 for 100 tablets[2].

Q: What are the challenges faced by the laxatives market? A: The market faces challenges such as potential side effects, strict regulatory standards, high development costs, and the lack of healthcare infrastructure in developing economies[3][4].

Q: Which region is expected to grow the fastest in the laxatives market? A: The Asia-Pacific region is expected to grow at the fastest CAGR due to the adoption of advanced technologies and growing demand for minimally invasive procedures[4].

Cited Sources

  1. ResearchAndMarkets.com: Global Laxatives Market (2020 to 2028)[1]
  2. Drugs.com: Gentle Laxative Prices, Coupons, Copay Cards & Patient Assistance[2]
  3. Data Bridge Market Research: Laxative Market is expected to reach USD 11,516.87 million by 2029[3]
  4. Market Research Future: Laxatives Market Analysis[4]

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.